A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreational Drug Users

Clinical trial NCT03286218 · COMPLETED

Trial details

NCT number: NCT03286218
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recreational Drug Use Prescription Drug Abuse (Not Dependent)

Start date: 2017-09-15
Primary completion: 2017-11-20
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.